Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 10-2002 | 07-2002 | 04-2002 | 01-2002 | 10-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,688 | 6,923 | 5,198 | 2,647 | 1,825 |
| Depreciation Amortization | 462 | 2,154 | 1,621 | 1,088 | 537 |
| Income taxes - deferred | N/A | 720 | N/A | N/A | N/A |
| Accounts receivable | -2,951 | -9,897 | -9,840 | -5,412 | -2,995 |
| Other Working Capital | 85 | -14,529 | -10,005 | -6,219 | -2,968 |
| Other Operating Activity | 5,070 | 24,187 | 18,628 | 11,652 | 6,367 |
| Operating Cash Flow | $6,354 | $9,558 | $5,602 | $3,756 | $2,766 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -186 | -620 | -402 | -318 | -139 |
| Purchase Sale Intangibles | -77 | -491 | -351 | -295 | -113 |
| Other Investing Activity | -78 | -505 | -361 | -293 | -116 |
| Investing Cash Flow | $-264 | $-1,126 | $-763 | $-611 | $-255 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23 | 128 | 128 | 67 | 33 |
| Dividend Paid | N/A | -97 | -96 | N/A | N/A |
| Financing Cash Flow | $23 | $31 | $32 | $67 | $33 |
| Beginning Cash Position | 67,135 | 58,671 | 58,671 | 58,671 | 58,671 |
| End Cash Position | 73,248 | 67,135 | 63,542 | 61,883 | 61,215 |
| Net Cash Flow | $6,113 | $8,464 | $4,871 | $3,212 | $2,544 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,354 | 9,558 | 5,602 | 3,756 | 2,766 |
| Capital Expenditure | -186 | -620 | -402 | -318 | -139 |
| Free Cash Flow | 6,168 | 8,938 | 5,200 | 3,438 | 2,627 |